Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
Klinikum / Johannes Gutenberg-Universität Mainz
Schmidt, M; Hengstler, JG; von Torne, C et al.
Coordinates in the universe of node-negative breast cancer revisited.Cancer Res. Bd. 69. H. 7. 2009 S. 2695-8
Boehm, D; Lebrecht, A; Keller, K et al.
Detection of breast cancer markers in serum by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF-MS)EJC SUPPLEMENTS. Bd. 7. H. 4. 2009 S. 12-12
Keller, K; Boehm, D; Lebrecht, A et al.
Development of a tool for reversed-phase protein microarrays (RPMA) and use in immunoproteomics of breast cancerEur J Cancer. Bd. 27. 2009 S. e22186
Lebrecht, A; Boehm, D; Schmidt, M et al.
Diagnosis of breast cancer by tear proteomic patternCancer Genomics Proteomics. Bd. 6. H. 3. 2009 S. 177-82
Geberth, M; Foerster, F; Klare, P et al.
Efficacy and Safety of First-Line Bevacizumab (BEV) Combined with Paclitaxel (PAC) According to Age: Subpopulation Analysis of a Large, Multicenter, Non-Interventional Study in Patients (Pts) with HER2-Negative Metastatic Breast Cancer (MBC).CANCER RESEARCH. Bd. 69. H. 24. 2009 S. 851S-852S
Keller, K; Böhm, D; Lebrecht, A et al.
Eine vielversprechende Methode zur Visualisierung der Antikörper-Profile in ImmunproteomicsSenologie - Zeitschrift für Mammadiagnostik und -therapie. Bd. 6. 2009 S. A61
Kalkum, G; Macchiella, D; Reinke, J et al.
Enzyme replacement therapy with agalsidase alfa in pregnant women with Fabry disease.Eur J Obstet Gynecol Reprod Biol. Bd. 144. H. 1. 2009 S. 92-3
Foerster, F; Geberth, M; Schumacher, C et al.
First-line bevacizumab (bev) plus paclitaxel (pac) combination therapy: safety findings (n=165) from a multicentre German non-interventional study in patients with metastatic breast cancer (MBC)EJC SUPPLEMENTS. Bd. 7. H. 2. 2009 S. 283-283
Petry, IB; Fieber, F; Gebhard, S et al.
HER-2/neu induces an anti-apoptotic expression patterns of Bcl-2 family members in node-negative Breast cancerGeburtshilfe und Frauenheilkunde. Bd. 69. H. 8. 2009 S. 754
Schmidt, M; Hesse, T; Kuehnle, H et al.
Ibandronate Shows Marked Pain Relief and a Favorable Renal Safety Profile - Updated Results of a Non Interventional Study in Breast Cancer Patients with Metastatic Bone DiseaseCANCER RESEARCH. Bd. 69. H. 24. 2009 S. 573S-573S
Schmidt, M; Boehm, D; Lebrecht, A et al.
Immunoglobulin Kappa C Has Independent Prognostic Significance in Node-Negative Breast CancerCANCER RESEARCH. Bd. 69. H. 24. 2009 S. 729S-729S
Schmidt, M; Petry, IB; Bohm, D et al.
Influence of Immunoglobulin Kappa C on the metastasis-free survival in adjuvant untreated node-negative Breast cancer.GEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 69. H. 8. 2009 S. 759-759
Skala, CE; Petry, IB; Gebhard, S et al.
Isolation of fibroblasts for coating of meshes for reconstructive surgery: differences between mesh types.Regen Med. Bd. 4. H. 2. 2009 S. 197-204
Naumann, G
Ist eine chirurgische Therapie der Mischinkontinenz sinnvoll?F. Perabo, S.C. Müller (Hrsg). Inkontinenz. 1. Aufl. Köln: Deutscher Ärzteverlag 2009
Naumann, G
Kann die Belastungsinkontinenz der Frau medikamentös behandelt werden?F.Perabo, S.C. Müller (Hrsg). Inkontinenz. 1. Aufl. München: Deutscher Ärzteverlag 2009
Schmidt, M; Victor, A; Bratzel, D et al.
Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer-025EFcomparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trialANNALS OF ONCOLOGY. Bd. 20. H. 2. 2009 S. 258-264
Schmidt, M; Seraphin, J; Luhn, B et al.
Major issues in the treatment of metastatic bone disease: renal safety and maintained bone pain effectiveness of ibandronate in breast cancer patients in clinical practice; interim results of a non interventional study in GermanyCANCER RESEARCH. Bd. 69. H. 2. 2009 S. 154S-154S
Hampel, C; Naumann, G; Thüroff, JW et al.
Management of complications after sling and mesh implantationsUrologe A. Bd. 48. H. 5. 2009 S. 496-509
Schmidt, M; Tramm, T; Bohm, D et al.
Molecular breast cancer prognosis in node negative early breast cancerCANCER RESEARCH. Bd. 69. H. 2. 2009 S. 127S-127S
Harbeck, N; Meisner, C; Ravdin, PM et al.
Outcome Prediction in Node-Negative Breast Cancer Based on ASCO-Recommended Biomarkers uPA/PAI-1 Using the Final 10-Year Analysis of the Randomized Multicenter Chemo N0 Trial Compared to Adjuvant Online (TM)CANCER RESEARCH. Bd. 69. H. 24. 2009 S. 719S-719S
Koelbl, H; Nitti, V; Baessler, K et al.
Pathophysiology of Urinary Incontinence, Faecal Incontinence and Pelvic Organ ProlapsePaul Abrams and the Scientific Committee (Hrsg). Incontinence. 4. Aufl. Paris: Health Publication 2009
Han, W; Kühne, S; Seufert, R et al.
Perinatal Outcome of twin Pregnancies after IVF / ICSIGeburtshilfe Frauenheilkd. Bd. 69. 2009 S. 131 – 134
Merkel, M; Tchirikov, M; Zschocke, J et al.
Phenylalanine tolerance in three phenylketonuric women pregnant with fetuses of different genetic PKU statusJ Inherit Metab Dis. Bd. 32. H. 1. 2009 S. 1-online first
Hohmann, M; Zoltan, D; Künzel, W et al.
Phenylephrine (PE) sensitivity is not affected by cyclooxygenase (COX) and nitric oxide (NO) pathways in mesenteric veins of pregnant ratsJ Perinat Med. Bd. 37. H. S1. 2009 S. 272
Passuello, V; Puhl, AG; Wirth, S et al.
Pregnancy Outcome in Maternal Crigler-Najjar Syndrome Type II: A Case Report and Systematic Review of the LiteratureFETAL DIAGNOSIS AND THERAPY. Bd. 26. H. 3. 2009 S. 121-126
Walter, C; Grötz, KA; kasaj, A et al.
Prevalence of bisphosphonate associated osteonecrosis of the jaws in breast cancer patientsActa Stomatol Croat. Bd. 43. H. 4. 2009 S. 271-278
Böhm, D; Lebrecht, A; Schmidt, M et al.
Primäres Leiomyosarkom der männlichen Brust. Ein seltener FallberichtSenologie - Zeitschrift für Mammadiagnostik und -therapie. Bd. 6. 2009 S. A17
Schmidt, M; Tramm, T; Bohm, D et al.
Prognosis of Distant Metastasis in Node-Negative Early Breast CancerCLINICAL CHEMISTRY. Bd. 55. H. 6. 2009 S. A112-A112
Stebel, A; Brachetti, C; Kunkel, M et al.
Progression of breast tumors is accompanied by a decrease in expression of the Rho guanine exchange factor Tiam1ONCOLOGY REPORTS. Bd. 21. H. 1. 2009 S. 217-222
Boehm, D; Lebrecht, A; Keller, K et al.
Proteome using protein chips in serum and tear fluid: identification of biomarkers for early detection of breast cancerGEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 69. H. 8. 2009 S. 736-736
Boehm, DU; Lebrecht, A; Eckhardt, T et al.
Quality of life and adjuvant tamoxifen treatment in breast cancer patientsEur J Cancer Care (Engl). Bd. 18. H. 5. 2009 S. 500-6
Sebastian, M; Hanusch, C; Schmidt, M et al.
Safety and antitumor activity of 3-weekly anti-EpCAM antibody adecatumumab (MT201) in combination with docetaxel for patients with metastatic breast cancer: Results of a multicenter phase Ib trialJOURNAL OF CLINICAL ONCOLOGY. Bd. 27. H. 15. 2009 S. -
Tchirikov, M
Successful Tracheal Occlusion Using Ultrathin Fetoscopic Equipment Combined with Real-Time Three-Dimensional UltrasoundEUROPEAN SURGICAL RESEARCH. Bd. 43. H. 2. 2009 S. 204-207
Tchirikov, M
Successful tracheal occlusion using ultttttrathin fetoscopic equipment combined with real-time three-dimensional ultrasoundEur Surg Res. Bd. 43. H. 2. 2009 S. 204-207
Lebrecht, A; Boehm, D; Schmidt, M et al.
Surface-enhanced Laser Desorption/Ionisation Time-of-flight Mass Spectrometry to Detect Breast Cancer Markers in Tears and SerumCancer Genomics Proteomics. Bd. 6. H. 2. 2009 S. 75-83
Kantelhardt, E; Thomssen, C; Vetter, M et al.
The determination of prognostic factors uPA and PAI 1 for risk evaluation in nodal negative breast cancer - experiences of NNBC 3-Europe studyGEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 69. H. 8. 2009 S. 748-748
Grimm, C; Kantelhardt, E; Heinze, G et al.
The prognostic value of four interleukin-1 gene polymorphisms in Caucasian women with breast cancer: a multicenter study.BMC Cancer. Bd. 9. 2009 S. 78
Naumann, G; Albrich, SB
Urogynäkologie in der PraxisDer Gynäkologe 2009. Bd. 42. H. 9. 2009 S. 461-468
Schmidt, M; von Toerne, C; Boehm, D et al.
Validation of the prognostic impact of Ep-CAM in untreated node-negative breast cancerBREAST. Bd. 18. 2009 S. S29-S29
Passuello, V; Seufert, R; Fischl, F
Von Kinderwunsch zur Geburt - mögliche Risiken und ProblemeJournal für Gynäkologische Endokrinologie. Bd. 3. H. 3. 2009 S. 12-16
Naumann, G
Welche konservativen Behandlungsverfahren bestehen für die Belastungsinkontinenz?F. Perabo, S.C. Müller (Hrsg). Inkontinenz. 1. Aufl. Köln: Deutscher Ärzteverlag 2009
Naumann, G
Welchen Stellenwert haben Netze in der Inkontinenzchirurgie?F. Perabo, S.C. Müller (Hrsg). Inkontinenz. 1. Aufl. Köln: Deutscher Ärzteverlag 2009
Naumann, G
Welches sind die Ergebnisse und Komplikationen nach urethralen Bändern (TVT, TVT-O)?F.Perabo, S.C. Müller (Hrsg). Inkontinenz. 1. Aufl. Köln: Deutscher Ärzteverlag 2009
Naumann, G
Welches sind die Möglichkeiten und Grenzen des BeckenbodentrainingsF. Perabo, S.C. Müller (Hrsg). Inkontinenz. 1. Aufl. Köln: Deutscher Ärzteverlag 2009
Perabo, F; Naumann, G
Wie entsteht eine Inkontinenz?F.Perabo, S.C. Müller (Hrsg). Inkontinenz. 1. Aufl. Köln: Deutscher Ärzteverlag 2009
Han, W; Shah, S; hansen, T et al.
Aggressive Angiomyxoma of the VulvaGeburtshilfe Frauenheilkd. Bd. 68. 2008 S. 934 – 937
Maltaris, T; Weigel, M; Mueller, A et al.
Cancer and fertility preservation: fertility preservation in breast cancer patientsBreast Cancer Res. Bd. 10. H. 2. 2008 S. 206
Tchirikov, M; Strohner, M; Popovic, S et al.
Cardiac output following fetoscopic coagulation of major placental vessels in fetal sheep.Ultrasound Obstet Gynecol. Bd. 32. H. 7. 2008 S. 917-22
Naumann, G
Chirurgie der HarninkontinenzGyn-Aktiv. Bd. 5. 2008 S. 75-76
Schmidt, M; von Toerne, C; Koelbl, H et al.
Coordinates od node-negative breast cancer revisitedCancer Res. Bd. 69. H. 7. 2008 S. 2695-2698
Tchirikov, M
Dilation of the ductus venosus by stent implantation increases placental blood perfusion in fetal sheep.Am J Obstet Gynecol. Bd. 198. H. 1. 2008 S. 138.e1-6
Strauss, HG; Haensgen, G; Dunst, J et al.
Effects of anemia correction with epoetin beta in patients receiving radiochemotherapy for advanced cervical cancerInt J Gynecol Cancer. Bd. 18. 2008 S. 515-524
Battista, MJ; Eichbaum, MH; Hosch, WP et al.
Extensive Osler-Rendu disease in a breast cancer patient: increasing hepatic arteriovenous malformations under endocrine therapy mimicking liver metastases.Onkologie. Bd. 31. H. 6. 2008 S. 328-31
Puhl, AG; Steiner, E; Kramer, WW et al.
Fetal urogenital sinus with consecutive hydrometrocolpos because of labial fusion: prenatal diagnostic difficulties and postpartal therapeutic management.Fetal Diagn Ther. Bd. 23. H. 4. 2008 S. 287-92
Trappe, HJ; Tchirikov, M
Herzrhythmusstorungen bei der Schwangeren und beim Fetus.Internist (Berl). Bd. 49. H. 7. 2008 S. 788-98
Boehm, D; Lebrecht, A; Maltaris, T et al.
Influence of resection volume on locoregional recurrence of breast cancerAnticancer Res. Bd. 28. H. 2B. 2008 S. 1207-11
Salvatore, S; Serati, M; Uccella, S et al.
Inter-observer reliability of three different methods of measuring urethrovesical mobility.Int Urogynecol J Pelvic Floor Dysfunct. Bd. 19. H. 11. 2008 S. 1513-7
Huber, A; Baschaat, AA; Bregener, C et al.
Laser coagulation of placental anastomoses with a 30 degrees fetoscope in severe mid-trimester twin-twin transfusion syndrome with anterior placentaUltrasound Obstet Gynecol. Bd. 31. 2008 S. 412-16
Schmidt, M; Boehm, D; Steiner, E et al.
Long-term outcome prediction by clinico-pathological risk classification algorithms in node-negative breast cancer – comparison between Adjuvant!, St. Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast-Cancer-3 (NNBC-3) trial.Ann Oncol. 2008 S. 29
Schmidt, M; Victor, A; Böhm, D et al.
Long-term prognostic impact of risk classifications in node-negative breast cancer - comparison between Adjuvant!, St. Gallen, and a novel risk algorithm used in the prospectively randomized Node-Negative-Breast-Cancer-3 trial (NNBC-3)EJC Suppl. Bd. 6. H. Sup6. 2008 S. 194-195
von Tempelhoff, GF; Heilmann, L; Rudig, L et al.
Mean maternal second-trimester hemoglobin concentration and outcome ofClin Appl Thromb Hemost. Bd. 14. 2008 S. 19-28
Boehm, D; Siggelkow, W; Koelbl, H
Medimanetöse Primärtherapie des OvarialkarzinomsFrauenarzt. Bd. 49. 2008 S. 918-921
Schmidt, M
Node-negative breast cancer: which patients should be treated?Breast Care. Bd. 3. 2008 S. 237-243
Wagg, A; Cardozo, L; Chapple, C et al.
Overactive Bladder and Continence Guidelines: implementation, inaction or frustration?Int J Clin Pract. Bd. 62. H. 10. 2008 S. 1588-93
Reed, NS; Mangioni, C; Malmstrom, H et al.
Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).Eur J Cancer. Bd. 44. H. 6. 2008 S. 808-18
Gehrmann, M; Schmidt, M; Brase, JC et al.
Prediction of paclitaxel resistance in breast cancer: is CYP1B1*3 a new factor of influence?Pharmacogenetics. Bd. 9. 2008 S. 969-974
Viale, G; Giobbie-Hurder, A; Regan, MM et al.
Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole.J Clin Oncol. Bd. 26. H. 34. 2008 S. 5569-75
Schmidt, M; Hasenclever, D; Schaeffer, M et al.
Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer.Clin Cancer Res. Bd. 14. H. 18. 2008 S. 5849-55
Weikel, W; Schmidt, M; Steiner, E et al.
Reconstructive plastic surgery in the treatment of vulvar carcinomas.Eur J Obstet Gynecol Reprod Biol. Bd. 136. H. 1. 2008 S. 102-9
Steiner, E; Pollow, K; Hasenvlever, D et al.
Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancerGynecol Oncol. Bd. 108. 2008 S. 569-576
Albrich, S; Naumann, G; Skala, C et al.
Rolle der Mini-Schlingen in der Behandlung der weiblichen BelastungsinkontinenzKontinenz aktuell. Bd. 10. 2008 S. 5-8
Seufert, R
Sinkende öffentliche Ressourcen - steigende Patientenanforderungen - Aktuelle Konzepte zur Fortentwicklung reproduktionsmedizinscher ZentrenLIT - Verlag - Koblenzer Beiträge zu Gesundheitsmanagement und Public Health. Münster: LIT - Verlag 2008
Schmidt, M; Bohm, D; von Torne, C et al.
The humoral immune system has a key prognostic impact in node-negative breast cancer.Cancer Res. Bd. 68. H. 13. 2008 S. 5405-13
Siggelkow, W; Boehm, D; Skala, C et al.
The influence of macrosomia on the duration of labor, the mode of delivery and intrapartum complications.Arch Gynecol Obstet. Bd. 278. H. 6. 2008 S. 547-53
von Minckwitz, G; du Bois, A; Schmidt, M et al.
Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a German breast group 26/breast international group 03-05 studyJ Clin Oncol. Bd. 27. 2008 S. 1999-2006
Hermes, M; Schormann, W; Brulport, M et al.
Trastuzumab therapy vs tetracycline controlled ERBB2 downregulation: influence on tumour development in an ERBB2-dependent mouse tumour model.Br J Cancer. Bd. 98. H. 9. 2008 S. 1525-32
Naumann, G
Ultraschalldiagnostik bei ProlapsR.Lange, J.Kocziszewski, G. Naumann (Hrsg). Ultraschallldiagnostik in der Urogynäkologie oder Pipilogie II: Praxis der Perinealsonographie (Taschenbuch. 1. Aufl. München: Akademischer Verlaug München 2008
Kölbl, H; Baessler, K
Ultrasound ImagineBaessler K, Schüssler B, Burgio KL, Moore KH, Norton PA,Stanton SL (Hrsg). Pelvic Floor Re-education. 2. Aufl. London: Springer 2008
Naumann, G; Koelbl, H
UrogynäkologieM. Kiechle (Hrsg). Repetitorium Gynäkologie und Geburtshilfe. 1. Aufl. München: Urban u. Fischer 2008
Peschers, UM; Tunn, R; Dejewski, C et al.
Urogynecological training, testing and treatment among gynecologists in Germany.Eur J Obstet Gynecol Reprod Biol. Bd. 140. H. 1. 2008 S. 118-23
Seufert, R; Passuello, V; Holze, V et al.
Zertifizierung von Kinderwunschzentren – Erfahrungen an der UFK MainzJ. Reproduktionsmed. Endocrinol. Bd. 5. 2008 S. 359-360
Maltaris, T; Kölbl, H; Seufert, R et al.
1.5 Fertilitätsprotektion bei malignen Erkrankungen: Kryokonservierung von Ovargewebe vs GnRH Analoga- wo liegt die ZukunftArch Gynecol Obstet. Bd. 276. 2007 S. 395
Puhl, AG; Steiner, E; Koelbl, H
Bild und Fall: Zystische Erweiterung im fetalen Becken.Gynakologe. Bd. 40. 2007 S. 484-486
Werling, M; Albrich, S; Skala, C et al.
Bio-Mesh SIS: Operative Deszensus-Versorgung mittels Bio-MeshGeburtshilfe Frauenheilkd. Bd. 67. H. 6. 2007 S. 690-691
Trappe, HJ; Tchirikov, M
Cardiac arrhythmias in the pregnant woman and the fetusInternist (Berl). Bd. 49. 2007 S. 788-90
du Bois, A; Pfisterer, J; Burchardi, N et al.
Combination therapy with pegylated liposomal doxorubicin and carboplatin in gynecologic malignancies: a prospective phase II study of the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and Kommission Uterus (AGO-K-Ut).Gynecol Oncol. Bd. 107. H. 3. 2007 S. 518-25
Dobler, B; Pohl, F; Bogner, L et al.
Comparison of direct machine parameter optimization versus fluence optimization with sequential sequencing in IMRT of hypopharyngeal carcinoma.Radiat Oncol. Bd. 2. 2007 S. 33
Dittrich, R; Mueller, A; Hoffmann, I et al.
Cryopreservation of complex systems: slow freezing has not had its day yetRejuvenation Res. Bd. 10. H. 1. 2007 S. 101-2; author reply 103-5
Kölbl, H
Deszensus/ProlapsThüroff, Joachim W. (Hrsg). Urologische Differenzialdiagnose. 2. Aufl. Stuttgart: Thieme 2007
Steiner, E; Plata, K; Interthal, C et al.
Diabetes mellitus is a multivariate independent prognostic factor in endometrial carcinoma: a clinicopathologic study on 313 patients.Eur J Gynaecol Oncol. Bd. 28. H. 2. 2007 S. 95-7
Dittrich, R; Maltaris, T; Kölbl, H
Die extrakorporale Perfusion der Schweineblase als experimentelles Modell der BlasenfunktionArch Gynecol Obstet. Bd. 276. 2007 S. 395
Maltaris, T; Kölbl, H; Naumann, G et al.
Die extrakorporale Perfusion des Schweineuterus und des Schweinedetrusors als experimentelles Modell in der Gynäkologie und UrogynäkologieGeburtshilfe Frauenheilkd. Bd. 68. 2007 S. 677
Laessing, U; Vehling-Kaiser, HJ; Fascing, F et al.
Evaluation of gemcitabine plus carboplatin in pretreated, metastic breast cancer patients: Final analysis of a phase II trialJ Clin Oncol. Bd. 25. 2007 S. 122
Tchirikov, M; Schreckenberger, M; Strohner, M et al.
Fetal positron emission tomography during acute hypoxia and after fetoscopic coagulation of major placental vesselsUltrasound Obstet Gynecol. Bd. 30. 2007 S. 435-436
Laessig, D; Stemmler, HJ; Vehling-Kaiser, U et al.
Gemcitabine and carboplatin in intensively pretreated patients with metastatic breast cancer.Oncology. Bd. 73. H. 5-6. 2007 S. 407-14
Schmidt, M; Boehm, D; von Törne, C et al.
Gene expression profiling identifies the key prognostic impact of the humoral immune system in node-negative breast cancerPLOS Medicine. 2007 S. 0
Siggelkow, W; Koelbl, H
Herausforderung AltersgynäkologieFrauenarzt. Bd. 48. H. 2. 2007 S. 2 - 6
Hawighorst-Knapstein, S; Brückner, D; Schönefuß, G et al.
Individuelle Informationsentwicklung hilft BrustkrebspatientinnenFrauenarzt. Bd. 48. H. 11. 2007 S. 2-5
Cupisti, S; Dittrich, R; Binder, H et al.
Influence of Body Mass Index on measured an Calculated Androgen Parameters in Adult Women with Hirsutism and PCOSExp Clin Endocr Diab. Bd. 115. H. 6. 2007 S. 380-6
Seufert, R; Maltaris, T; Passuello, V et al.
Inhibine und Aktivin A beim PCO SyndromJ Reprod Med. Bd. 4. 2007 S. 257 - 258